INS and thanatophoric dysplasia type 1: Intraocular insulin therapy has been shown to be more effective and immune-modulating than the liver transplantation site in the long-term improvement of hyperglycemia in mouse and nonhuman primate models of TD1.[51,52] Bone marrow stands out as an alternative option for pancreatic IT due to its unique environment.